Cargando…
Restin protein expression in non‐small cell lung cancer
BACKGROUND: Restin is a member of the melanoma‐associated antigen (MAGE) superfamily. Its expression has been reported to be up‐ or downregulated in cancer. Preclinical data suggest it is a tumor suppressor. In this study, we aimed to evaluate restin expression and prognostic value in non‐small cell...
Autores principales: | Nana, Frank Aboubakar, Lamberts, Virginie, Hoton, Delphine, Stanciu, Claudia Pop, Lecocq, Marylène, Carlier, François M., Duplaquet, Fabrice, Pirard, Lionel, Pilette, Charles, Bihin, Benoît, Ocak, Sebahat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423652/ https://www.ncbi.nlm.nih.gov/pubmed/37365889 http://dx.doi.org/10.1111/1759-7714.15019 |
Ejemplares similares
-
Increased Expression and Activation of FAK in Small-Cell Lung Cancer Compared to Non-Small-Cell Lung Cancer
por: Aboubakar Nana, Frank, et al.
Publicado: (2019) -
Systemic Inflammation/Nutritional Status Scores Are Prognostic but Not Predictive in Metastatic Non-Small-Cell Lung Cancer Treated with First-Line Immune Checkpoint Inhibitors
por: Mahiat, Cédric, et al.
Publicado: (2023) -
Long-term complete remission after severe pembrolizumab-induced immune-related encephalitis in metastatic lung adeno-squamous carcinoma: A case report
por: Quirynen, Rémy, et al.
Publicado: (2023) -
Case report: BRAF A598-T599insV mutation as a potential resistance mechanism to alectinib in ALK-rearranged lung adenocarcinoma
por: Pasau, Thomas, et al.
Publicado: (2022) -
Targeting BRAF Activation as Acquired Resistance Mechanism to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small-Cell Lung Cancer
por: Aboubakar Nana, Frank, et al.
Publicado: (2021)